Cargando…
Targeting splicing factors for cancer therapy
Alternative splicing (AS) of mRNAs is an essential regulatory mechanism in eukaryotic gene expression. AS misregulation, caused by either dysregulation or mutation of splicing factors, has been shown to be involved in cancer development and progression, making splicing factors suitable targets for c...
Autores principales: | Bashari, Ariel, Siegfried, Zahava, Karni, Rotem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019363/ https://www.ncbi.nlm.nih.gov/pubmed/36697261 http://dx.doi.org/10.1261/rna.079585.123 |
Ejemplares similares
-
Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer
por: Siegfried, Zahava, et al.
Publicado: (2013) -
A novel Plasmodium falciparum SR protein is an alternative splicing factor required for the parasites’ proliferation in human erythrocytes
por: Eshar, Shiri, et al.
Publicado: (2012) -
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer
por: Jbara, Amina, et al.
Publicado: (2023) -
SpliceAI-visual: a free online tool to improve SpliceAI splicing variant interpretation
por: de Sainte Agathe, Jean-Madeleine, et al.
Publicado: (2023) -
Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment
por: Mogilevsky, Maxim, et al.
Publicado: (2018)